PL1701730T3 - Sposób i szczepionka zawierająca kopolimer 1 do leczenia zaburzeń psychicznych - Google Patents
Sposób i szczepionka zawierająca kopolimer 1 do leczenia zaburzeń psychicznychInfo
- Publication number
- PL1701730T3 PL1701730T3 PL04801601T PL04801601T PL1701730T3 PL 1701730 T3 PL1701730 T3 PL 1701730T3 PL 04801601 T PL04801601 T PL 04801601T PL 04801601 T PL04801601 T PL 04801601T PL 1701730 T3 PL1701730 T3 PL 1701730T3
- Authority
- PL
- Poland
- Prior art keywords
- vaccine
- copolymer
- treatment
- psychiatric disorders
- psychiatric
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0007—Nervous system antigens; Prions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Anesthesiology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52776303P | 2003-12-09 | 2003-12-09 | |
| EP04801601.8A EP1701730B1 (en) | 2003-12-09 | 2004-12-09 | Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders |
| PCT/IL2004/001115 WO2005056574A2 (en) | 2003-12-09 | 2004-12-09 | Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1701730T3 true PL1701730T3 (pl) | 2014-04-30 |
Family
ID=34676774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04801601T PL1701730T3 (pl) | 2003-12-09 | 2004-12-09 | Sposób i szczepionka zawierająca kopolimer 1 do leczenia zaburzeń psychicznych |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20160213762A1 (pl) |
| EP (1) | EP1701730B1 (pl) |
| JP (1) | JP4808631B2 (pl) |
| AU (1) | AU2004297044B2 (pl) |
| CA (1) | CA2548310C (pl) |
| DK (1) | DK1701730T3 (pl) |
| ES (1) | ES2435417T3 (pl) |
| PL (1) | PL1701730T3 (pl) |
| PT (1) | PT1701730E (pl) |
| SI (1) | SI1701730T1 (pl) |
| WO (1) | WO2005056574A2 (pl) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL113812A (en) | 1994-05-24 | 2000-06-29 | Yeda Res & Dev | Copolymer-1 pharmaceutical compositions containing it and its use |
| US6391922B1 (en) * | 1998-01-13 | 2002-05-21 | Synchroneuron, Llc | Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders |
| AU766498B2 (en) | 1998-07-23 | 2003-10-16 | President And Fellows Of Harvard College, The | Synthetic peptides and methods of use for autoimmune disease therapies |
| CA2337688C (en) | 1998-07-23 | 2016-04-05 | Yeda Research And Development Co., Ltd. | Treatment of autoimmune conditions with copolymer 1 and related copolymers |
| PT1248643E (pt) | 2000-01-20 | 2005-10-31 | Yeda Res & Dev | Utilizacao de copolimero 1 e peptidos e polipeptidos congeneres e de celulas t tratadas co estes compostos para terapia neuroprotectora |
| EP1294390B1 (en) * | 2000-06-07 | 2006-01-04 | YEDA RESEARCH AND DEVELOPMENT CO., Ltd. | The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotection from glutamate toxicity |
| AU2002240057A1 (en) * | 2001-01-24 | 2002-08-06 | President And Fellows Of Harvard College | Therapeutic peptides for demyelinating conditions |
| US6835711B2 (en) * | 2001-06-28 | 2004-12-28 | Yeda Research And Development Co. Ltd. | Use of poly-Glu,Tyr for neuroprotective therapy |
| KR20040081431A (ko) | 2001-12-06 | 2004-09-21 | 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 | 운동신경 질환의 치료용 백신 및 치료 방법 |
| US20080085269A1 (en) * | 2003-11-12 | 2008-04-10 | Michal Eisenbach-Schwartz | Vaccine And Method For Treatment Of Neurodegenerative Diseases |
-
2004
- 2004-12-09 EP EP04801601.8A patent/EP1701730B1/en not_active Expired - Lifetime
- 2004-12-09 DK DK04801601.8T patent/DK1701730T3/da active
- 2004-12-09 ES ES04801601T patent/ES2435417T3/es not_active Expired - Lifetime
- 2004-12-09 WO PCT/IL2004/001115 patent/WO2005056574A2/en not_active Ceased
- 2004-12-09 JP JP2006543716A patent/JP4808631B2/ja not_active Expired - Fee Related
- 2004-12-09 PT PT48016018T patent/PT1701730E/pt unknown
- 2004-12-09 AU AU2004297044A patent/AU2004297044B2/en not_active Ceased
- 2004-12-09 PL PL04801601T patent/PL1701730T3/pl unknown
- 2004-12-09 SI SI200432113T patent/SI1701730T1/sl unknown
- 2004-12-09 CA CA2548310A patent/CA2548310C/en not_active Expired - Fee Related
-
2016
- 2016-04-11 US US15/095,300 patent/US20160213762A1/en not_active Abandoned
-
2017
- 2017-12-28 US US15/856,863 patent/US20180207249A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP4808631B2 (ja) | 2011-11-02 |
| CA2548310C (en) | 2014-02-18 |
| PT1701730E (pt) | 2013-11-27 |
| US20180207249A1 (en) | 2018-07-26 |
| CA2548310A1 (en) | 2005-06-23 |
| US20160213762A1 (en) | 2016-07-28 |
| WO2005056574A2 (en) | 2005-06-23 |
| EP1701730A4 (en) | 2009-08-19 |
| SI1701730T1 (sl) | 2014-01-31 |
| ES2435417T3 (es) | 2013-12-19 |
| EP1701730A2 (en) | 2006-09-20 |
| AU2004297044A1 (en) | 2005-06-23 |
| WO2005056574A3 (en) | 2006-02-16 |
| DK1701730T3 (da) | 2013-11-25 |
| JP2007520457A (ja) | 2007-07-26 |
| EP1701730B1 (en) | 2013-08-21 |
| AU2004297044B2 (en) | 2010-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1509279A4 (en) | DEVICE AND METHOD FOR THE TREATMENT OF HEART DISEASES | |
| HUS1500043I1 (hu) | Eljárások Parkinson-kór kezelésére | |
| AU2003286567A8 (en) | Methods for the treatment of skin disorders | |
| IL161865A0 (en) | Method and apparatus for the stimulation of growth | |
| EP1578367A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES | |
| EP1572116A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES | |
| EP1576137A4 (en) | COMPOSITIONS AND METHODS FOR TREATING DISEASES RELATED TO THE IMMUNE SYSTEM | |
| EP1471909A4 (en) | PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM | |
| IL174918A0 (en) | Methods and reagents for the treatment of immunoinflammatory disorders | |
| IL174185A0 (en) | Methods and reagents for the treatment of immunoinflammatory disorders | |
| AU2002351378A8 (en) | Method and apparatus for treatment of amblyopia | |
| EP1699431A4 (en) | COMPOSITIONS FOR THE TREATMENT OF EARLIER DISEASES AND APPLICATION PROCEDURES | |
| HUP0501017A3 (en) | Methods and compositions for treatment of central nervous system disorders | |
| AU2003296341A8 (en) | System and method for treating Parkinson's Disease and other movement disorders | |
| AU2003287909A8 (en) | Electro-therapeutic device and method of electro-therapeutic treatment | |
| EP1680145A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISEASES | |
| PL373565A1 (pl) | Sposoby i kompozycje do leczenia zaburzeń związanych z nieprawidłowościami immunologicznymi | |
| IL165216A0 (en) | Methods of treating gastrointestinal and genitouririnary pain disorders using vinlafaxin and derivatives | |
| PL371281A1 (pl) | Sposoby i kompozycje do leczenia chorób oczu | |
| AU2003272728A8 (en) | Methods and compositions for treatment of neurological disorder | |
| AU2001271887A1 (en) | Methods for diagnosis and treatment of psychiatric disorders | |
| AU2002362115A8 (en) | Composition and methods for treatment of neurological disorders | |
| IL166062A0 (en) | Compositions and methods for therapeutic treatment | |
| EP1539100A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISORDERS | |
| IL162053A0 (en) | Method for the treatment of bone disorders |